Trial Profile
Influence of Combined Therapy of Niacin and Statins on Stem Cell Mobilization and Inflammatory Parameters in Patients Suffering From Coronary Artery Disease - Randomized Clinical Study -
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs HMG-CoA reductase inhibitors (Primary) ; Niacin (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms NASPOCAD